Journal of Lipid Research, Vol 35, 399-407, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47

SG Young, RK Koduri, RK Austin, DJ Bonnet, RS Smith and LK Curtiss
Gladstone Institute for Cardiovascular Disease, Department of Medicine, University of California, San Francisco 94141-9100.

The apolipoprotein (apo) B-100-specific monoclonal antibody MB47 has been widely used in lipoprotein metabolism and atherosclerosis research. When bound to apoB-100 on low density lipoproteins (LDL), antibody MB47 completely blocks the binding of LDL to the LDL receptor. The epitope for antibody MB47 has previously been mapped to the vicinity of apoB-100 amino acid (aa) residue 3500. To map the epitope for antibody MB47 more precisely, we used recombinant bacterial fusion proteins. Antibody MB47 bound strongly to a fusion protein containing apoB-100 aa 3214-3728, but no specific binding was observed to fusion proteins containing aa 3214-3351, 3214-3506, 3351-3506, or a fusion protein containing aa 3214-3351 and 3506-3728. Although antibody MB47 did not bind to aa 3214-3506, it did bind to aa 3214-3510. Further fusion protein studies revealed that antibody MB47 bound to aa 3429- 3510, but bound only very weakly to aa 3453-3510, indicating that aa 3429-3453 constitute an important part of the MB47 epitope. Subsequent fusion protein studies revealed that MB47 bound much more strongly to aa 3429-3523, 3429-3544, 3429-3565, and 3429-3590 than to aa 3429-3510. Thus, aa 3507-3523 also constitute an important part of the MB47 epitope. In summary, the fusion protein data indicated that two nonlinear domains of apoB-100 separated by approximately 53 aa (the 25 residues from aa 3429 to 3453 and the 17 residues from aa 3507 to 3523) form key parts of the MB47 epitope.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				X. Wang, R. Pease, J. Bertinato, and R. W. Milne Well-Defined Regions of Apolipoprotein B-100 Undergo Conformational Change During Its Intravascular Metabolism Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1301 - 1308. [Abstract] [Full Text] [PDF]

				C. H. Zlot, L. M. Flynn, M. M. Véniant, E. Kim, M. Raabe, S. P. A. McCormick, P. Ambroziak, L. M. McEvoy, and S. G. Young Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice J. Lipid Res., January 1, 1999; 40(1): 76 - 84. [Abstract] [Full Text]

				S. Y. Choi, I. J. Goldberg, L. K. Curtiss, and A. D. Cooper Interaction between ApoB and Hepatic Lipase Mediates the Uptake of ApoB-containing Lipoproteins J. Biol. Chem., August 7, 1998; 273(32): 20456 - 20462. [Abstract] [Full Text] [PDF]

				S. P. A. McCormick, J. K. Ng, C. M. Cham, S. Taylor, S. M. Marcovina, J. P. Segrest, R. E. Hammer, and S. G. Young Transgenic Mice Expressing Human ApoB95 and ApoB97. EVIDENCE THAT SEQUENCES WITHIN THE CARBOXYL-TERMINAL PORTION OF HUMAN apoB100 ARE IMPORTANT FOR THE ASSEMBLY OF LIPOPROTEIN(a) J. Biol. Chem., September 19, 1997; 272(38): 23616 - 23622. [Abstract] [Full Text] [PDF]

				R. Kalluri, M. J. Sun, B. G. Hudson, and E. G. Neilson The Goodpasture Autoantigen J. Biol. Chem., April 12, 1996; 271(15): 9062 - 9068. [Abstract] [Full Text] [PDF]

				M. Kaartinen, A. Penttila, and P. T. Kovanen Extracellular Mast Cell Granules Carry Apolipoprotein B-100–Containing Lipoproteins Into Phagocytes in Human Arterial Intima : Functional Coupling of Exocytosis and Phagocytosis in Neighboring Cells Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 2047 - 2054. [Abstract] [Full Text]

				J. Boren, U. Ekstrom, B. Agren, P. Nilsson-Ehle, and T. L. Innerarity The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100 J. Biol. Chem., March 16, 2001; 276(12): 9214 - 9218. [Abstract] [Full Text] [PDF]